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Retroviral Transfer of the Recombinant Human Erythropoietin Receptor Gene Into Single Hematopoietic Stem/Progenitor Cells From Human Cord Blood Increases the Number of Erythropoietin-Dependent Erythroid Colonies
By Li Lu, Yue Ge, Zhi-Hua Li, Winnie Keeble, David Kabat, Grover C. Bagby, Hal E. Broxmeyer, and Maureen E. Hoatlin
To test whether an enforced expression of a lineage-specific cytokine receptor would influence the proliferation/differentiation of hematopoietic stemlprogenitor cells, retroviral vectors containing the human erythropoietin receptor (hEpoR) gene were used to transduce the hEpoR gene into phenotypically sorted subsets of cells. CD34+++, CD34++CD33-, and CD34++CD33+ populations of human cord blood, highly enriched for hematopoietic stem/progenitor cells, were sorted and plated as single cells per well in methylcellulose culture medium containing early acting growth factors in the presence or absence of Epo. The hEpoR gene was efficiently transduced into single high proliferative potential colony-forming cells (HPP-CFC) and multipotential (colony-forming unit granulocyte, erythroid, monocyte, megakaryocyte [CFU-GEMMI), erythroid (burst-forming unit-erythroid [BFU-E]), and granulocyte-macrophage (colony-forming unit-granulocyte-macrophage [CFU-GM11 pro-RYTHROPOIETIN (Epo) is a principal regulator of erythropoiesis in mammals and stimulates the proliferation and differentiation of erythroid progenitor cells.' Epo receptors (EpoR) have been identified primarily on erythroid progenitors, fetal liver cells, placental cells, megakaryocytes, and several hematopoietic cell lines.'-* The murine and human EpoR have been isolated and cloned by several groups. The EpoR is a member of the cytokine recepor superfamily and lacks a kinase domain. Binding of Epo to the EpoR induces rapid tyrosine phosphorylation of a series of cellular substrates. '8-2' How hematopoietic stem and progenitor cells commit themselves to a specific lineage is beginning to be evaluated. Expression of lineage-specific growth factor receptors by these cells is clearly of importance in at least the timing of a specific cellular response towards proliferation and differentiation. For example, expression of the EpoR in interleukin-3 (IL-3)-dependent cell lines allows these cells to proliferate in response to E~o . * *~'~ To determine whether a similar effect would occur in normal progenitor cells, purified early subsets of hematopoietic stem and progenitor cells from human umbilical cord blood were transduced by retroviral mediated gene transfer with a gene for the EpoR. We chose cord blood as a target for gene transfer because it is enriched for early primitive cells with extensive proliferative capacity and because these cells can be and transduced at high efficiency using viral at the level of a single sorted and isolated cell.3z We also sought to transduce single cells and allow these cells to grow in the absence of other cells at the start of culture to support more strongly the idea that the proliferatioddifferentiation profile of stem/ progenitor cells can be influenced specifically by expression of an inserted gene encoding a cytokine receptor. To evaluate the possibility that introduction of exogenous sequences of the EpoR gene could influence the proliferatioddifferentiation capacity of individual cells, populations of either E Blood, Vol 87, No 2 (January 15). 1996: pp 525-534 genitor cells. As expected in cultures grown in the absence of Epo, no BFU-E or CFU-GEMM colonies grew. In the presence of Epo, the hEpoR-gene transduced cells formed significantly more CFU-GEMM and BFU-E colonies than did the controls. A significant decrease in HPP-CFC colonies was also observed under these conditions. Little or no effect of hEpoR gene transduction was apparent in the numbers of CFU-GM colonies formed in the presence or absence of Epo. All of the above results were similar whether the cell populations assessed were CD34+++ or their CD33-or CD33' subsets plated in the presence of growth factors at 200 cells/ mL or after limiting dilution at 2 cells/well. These results suggest that the profile of detectable stem/progenitors can be altered by retrovirus-mediated expression of the hEpoR gene.
0 1996 by The American Society of Hematology.
CD34+++ cells or CD34++ subsets of CD33-and CD33+ cells were sorted as a single cell per well, transduction was performed with retroviral vectors that encode hEpoR, and then single cells were assessed for their capacity to form colonies of distinct hematopoietic lineages.
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CD34"CD33-and CD34"CD33' cells were sorted from NALT-, cells as previously described?? The CD34++CD33-subset is relatively enriched for erythroid progenitor cells (colony-forming unit-erythroid [CFU-E] and burst-forming unit-erythroid [BFU-E]) and the CD34++CD33+ subset is relatively enriched for granulocytemacrophage progenitors (colony-forming unit-granulocyte-macrophage [CFU-GM])." Phenotyped cells were directly sorted by an autoclone device as a single cell into single wells containing 0.1 mL semisolid culture medium and a single cell per well was verified as described,*' or these cells were plated at 200 cellslml or after limiting dilution at 2 cellslwell.
Colony assay. Cultures contained Iscove's modified Dulbecco's medium (IMDM; GIBCO BRL, Gaithersburg, MD), 1 % methylcellulose, 30% fetal calf serum (FCS; Hyclone Laboratory, Logan, UT), and 0.1 mmoVL hemin (Eastman Kodak CO, Rochester, NY). Recombinant human steel factor (rhSLF), IL-3, and granulocytemacrophage colony-stimulating factor (GM-CSF) were kind gifts from Immunex Corp (Seattle, WA) and were used respectively at SO ng/mL, 200 UlmL, and 200 UlmL. rhEpo was purchased from Amgen Corp (Thousand Oaks, CA) and was used at 1 UlmL, unless otherwise indicated. Cells were incubated under humidified conditions at 37"C, S% 02, and 5% CO, for 14 days. The criteria for distinguishing high proliferative potential colony-forming cell (HPP-CFC)-derived colonies has been reported as greater than I mm diameter with a dense center and composed of greater than IO' cells/ colony." Retroviral vectors. The retroviral vector encoding hEpoR, pSFFhEpoR, was constructed from a three-way ligation of the following fragments: a BamHVXho I pSFF vector fragment, Bgl II/ BssHII, and a BssHIYXho I fragment from the hEpoR-encoding plasmid p18 (a gift from G. Wong, Genetics Institute, Cambridge, MA), as previously described.2'.'6 The pLhEpoRSN retroviral vector encodes hEpoR and neomycin phosphotransferase (neo) genes and was constructed from an EcoRVXho I fragment containing the EpoR coding sequence inserted into the cloning site of the pLXSN vector (a gift from Dr A. Dusty Miller, Fred Hutchinson Cancer Center, Seattle, WA).
Retroviral packaging cell lines. Retroviral packaging cell lines, $-2'7 and PAL','' were maintained in Dulbecco's modified Eagle's medium supplemented with 10% FCS. 14-2 and PA12 cells were transfected with retroviral vectors encoding hEpoR to produce helper-free virions by ping-pong amplification, as previously de~c r i b e d .~' .~~
The titer for LhEpoRSN virus was performed by standard methods4' and ranged from S X 10' to IO6 (3418-resistant (G418R) CFUlmL on NIH3T3 cells. Viral supematant was harvested and filtered through 0.45-pm or 0.22-pm filters and stored at -80°C until use.
Retroviral tramduction protocol.
Single CD34'
CD34" CD33-, or CD33' CB cells were sorted into single wells containing 0.1 mL methylcellulose3* in the presence of the growth factors indicated in the text and legends to the tables and figures and at the concentrations and conditions indicated above. The cells were grown for 2 days and viral supernatant was added once at 20 pL/well with polybrene (final concentration, 8 pg/mL). G418 was added 40 hours later at 1 mg/mL for the assessment of G418R colony-forming unit granulocyte, erythroid, monocyte, megakaryocyte (Cm-GEMM), BFU-E, and CFU-GM and at 12 pg/mL for the assessment of G418' HPP-CFC.'* The amount of G418 used was determined empirically by dose response and is given as dry weight. The cells remained in the same growth factor medium throughout the study. We had previously documented that the transducing capacity of a retroviral vector was completely lost between 6 and 24 hours of incubation of the virus at 37°C and that examination of CD34"' cells sorted as a single cell/well showed that, at a time equivalent to 24 hours after the addition of virus to single cells, greater than 97% of the wells still contained only single cells.'* Similar studies were repeated with the viral preparations used herein, which showed that the activity of the virus was completely lost at a time when less than 2% of the cells had formed doublets. Thus, it is likely that in greater than 97% of the cases, single cells had been transduced in the present experiments. An alternative protocol was also used in which separated cells were first grown for 2 days in the presence of SLF, GM-CSF, and IL-3 before transduction and washing of the cells (2 times). The cells were then plated at either 200 cellslml or after limiting dilution at 2 cellslwell in the presence of SLF, GM-CSF, and IL-3; in the absence and presence of Epo; or in the presence of IL-3 with and without Epo. In all cases, except that shown in Table I , the effects of the hEpoR cDNA containing viruses were compared to that of mock virus controls in which the same vector without the hEpoR cDNA insert was used. In most cases, the mock control groups were compared with medium control treated groups.
The probability of significant differences between groups in the single cell and two cellslwell experiments was determined by ,yz test, and that between cells plated at 200 cells/mL (expressed as mean t I SEM) was determined by Student's t-test.
Polymeruse chain reaction (PCR) analysis. Genomic DNA was isolated from individual colonies as previously described." Briefly, individual colonies were removed from methylcellulose culture medium and washed with 1 mL of phosphate-buffered saline (PBS). Cell pellets were resuspended in the small volume of remaining PBS to which 200 pL of a chelex 100 solution (200 to 400 mesh: BioRad, Richmond, CA) was added. Cells were mixed well with chelex and lysed by boiling for S minutes, chilled on ice for S minutes, and pelleted for 30 seconds at 2,800g.'* Ten microliters of supernatant from the lysate was used for PCR. The plasmid DNA of pSFF hEpoR and pLhEpoRSN was used as PCR positive controls. As a negative control, DNA was obtained from cells incubated with viral supernatant collected from packaging cell lines that had been transfected with the retroviral vector lacking the EpoR cDNA insert (mock control). Two pairs of primers were used at 1 pmol/L in the PCR reaction (see Fig I for PCR primer positions). For cells incubated with SFFhEpoR virus, the following primers were used: 5'GGTATCTGACTCTGGCATCTC 3'(reddues: 1478-1 499 sense strand of hEpoR cDNA sequences") and S'GGCCTGTATGGT-CAGCATAGA 3' (residues: 1244-1265 antisense strand of pSFF LTR4*). Each sample was amplified with AmpliTaq (Perkin Elmer/ Cetus, Roche Molecular Systems, Inc. Branchburg, NU using a DNA thermocycler (Perkin-Elmer/Cetus) for 35 cycles (94°C for l minute to denature the DNA, 58°C for 1 minute for primer annealing, and 72°C for 1 minute for primer extension), as previously described.'' For analysis of cells incubated with LhEpoRSN virus, the following PCR primers were used: 5'GGTATCTGACTCTGGCATCTC 3' (residues: 1478-1499 hEpoR sense strand) and S'ACCTGCGTG-CAATCCATCTTG 3' (residues: 1068-1088 anti-sense strand) corresponding to the neo gene of the pLXSN vector. Each sample was amplified for 35 cycles (94°C for 1 minute, 62°C for 1 minute, and 72°C for 2 minutes). Ten microliters of reaction mixture was electrophoresed on a 1 % agarose gel. To ensure that amplified products were the correct sequences, Southern blot analysis was performed by standard methods using a labeled internal hEpoR gene fragment, a pSFF vector fragment, and a neo fragment of pLXSN vector as probes.
Reverse transcriptuse-PCR (RT-PCR) analysis. RNA was extracted from individual colonies by a modified m e t h~d .~' ,~ Briefly, colonies were removed from cultures as described above. Cell pellets were resuspended in 20 FL double distilled water treated with dimethyl pyrocarbonate (DEPC), 100 U RNasin, and I pg tRNA; cooled in ice for 30 minutes; and pelleted for 30 seconds. A 9-pL supernatant of the resulting RNA solution was used in the RT reaction. To eliminate contaminating DNA, the RNA extracts were use only. for the RT-PCR reaction. The primers for RT-PCR reaction were S'CCCCTACCCACCCCACCTAA 3' (residues: 1442-1462 sense strand) of hEpoR cDNA and the 1068-1088 antisense neo primer as described above. Forty-five cycles in the following sequence were performed: denaturation at 95°C for 25 seconds, annealing at 65°C for 30 seconds, and polymerization at 72°C for 2 minutes. As a negative control for the RT-PCR reaction, the RNA extracts were used for PCR analysis without adding RT to ensure that the amplified products were mRNA, but not genomic DNA that might contain integrated viral cDNA. These results were obtained from four separate experiments. The points represent a range of 192 to 2,112 wells that were evaluated. In the absence of Epo, no BFU-E or CFU-GEMM colonies were detected in the mock-or SFF-hEpoR-treated cells, but a significant 88% decrease in HPP-CFC colonies was apparent in the SFFhEpoR-treated cells. In the presence of Epo, significantly increased numbers of BFU-E (2.0-to 2.5-fold) and CFU-GEMM (2-fold) and significantly decreased numbers of HPP-CFC (54% to 80%) were noted in the SFF-hEpoR versus mock controls. Significant changes in BFU-E colonies were seen at 0.2 to 1.0 U Epo/mL and at 1.0 U EpolrnL for CFU-GEMM colonies, whereas the significant decreases in HPP-CFC colonies were seen at the full range of Epo concentrations (0. l to 1 .O U/mL). A slight but significant 1.2-fold increase in CFU-GM colonies was noted at 1.0 U Epo/ mL. Not only were the numbers of BFU-E colonies increased in the SFF-hEpoR-treated cells stimulated by Epo, but the size of these colonies was 40% to 100% larger (as estimated visually) than in the mock virus-treated cells. The total cloning efficiency of the CD34+++ cells at the single isolated cell level reached greater than 70% in the SFF-hEpoRtreated cells grown in the presence of 1.0 U Epo/mL plus SLF, GM-CSF, and IL-3. To verify transduction of the CD34+++ cells, individual colonies were selected randomly for PCR analysis. PCR primers were designed so that a 366-A pSFF-hEpoR bp fragment would be amplified in cells transduced by the SFF-hEpoR virus. A Southern blot was performed using 32P-labeled probes of either the hEpoR or pSFF vector to confirm that the amplified material was correct (Fig 3) . Because the 3' PCR primer used corresponded to the retroviral LTR, retroviral EpoR and not endogenous EpoR would be detected. From a total of 121 colonies, the expected 366-bp products were detected in 45 colonies (37%). This included 41% PCR' HPP-CFC (18/44; number of PCR' colonies/ total colonies evaluated), 38% PCR+ BFU-E (1 1/29), 42% PCR+ CFU-GEMM (10/24), and 25% PCR' CFU-GM (6/ 24). All 20 control colonies derived from the mock-infected cells were negative by PCR and Southern blot for virally encoded hEpoR. The results show detection of PCR products from the transduced hEpoR gene in the different progenitor cells.
RESULTS
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To verify the biologic results in Fig 2, the studies were repeated using another hEpoR-containing vector, pLhEpo-RSN, that encodes neomycin phosphotransferase, a dominant selectable marker gene (Fig IB) . As shown in Fig 4  (no G418 used) , the results for cells stimulated with SLF, IL-3, and GM-CSF in the absence and presence of increasing concentrations of Epo (Fig 4A) were similar to that seen in Fig 2 using SFF-hEpoR . The cells treated with LhEpoRSN had 50% to 70% significantly decreased numbers of HPP-CFC colonies compared with the mock-infected controls regardless of whether Epo was added to the wells and 2.0-to 6.0-fold significantly increased numbers of BFU-E colonies (at 0.1 to 1 .O U Epo/mL) and 1.6-fold significantly increased numbers of CFU-GEMM colonies (at 1.0 U Epo/mL). To see if results were the same if no HPP-CFC grew, IL-3 was added but SLF and GM-CSF were left out of the cultures (Fig 4B) . No HPP-CFC colonies were detected in SLF-and GM-CSF-minus media and BFU-E and CFU-GEMM colonies only grew when Epo was added in these cultures.
The LhEpoRSN-treated cells had significantly greater numbers of BFU-E colonies by 2.2-to 3.0-fold (at 0.5 to 1.0 U Epo/mL) and CFU-GEMM colonies by 2.0-fold (at 1.0 U Epo/mL) than the mock-infected controls. As noted above for the SFF-hEpoR-treated cells, those cells treated with LhEpoRSN had BFU-E colonies larger in size than the mock-infected control cells. The respective cloning efficiencies for EpoR transduced cells grown in the presence of 1.0 U Epo/mL with either SLF, GM-CSF, and IL-3 ( Fig 4A) or with IL-3 and Epo (Fig 4B) were, respectively, 74% and 50%.
To evaluate the transduction efficiency of the LhEpoRSNtreated cells, the cells were grown in the presence of either 1 .O mg G418/mL to determine the percentage of G41 8R CFU-GEMM, BFU-E, and CFU-GM colonies or in the presence of 12.0 pg G418/mL to better identify the G418R HPP-CFC (Table 1 ). Our previous studieg2 had shown that few or no G418R HPP-CFC colonies grew in the presence of 1 .O to 1 .S mg G41 8/mL, but that most G41 8R HPP-CFC surviving 12.0 pg G418/mL were PCR' for the inserted gene. In the presence of I .O mg G41 8/mL, 62% to 67% G41 8R-CFU-GEMM, -BFU-E, and -CFU-GM colonies were detected, whereas in the presence of 12.0 pg G41 8/mL, 50% G41 8R-HPP-CFC colonies were seen ( Table l) . Only 3% of colonies from nontransduced cells survived at I mg/mL of G418. Transduction of single CD34++CD33-and CD34" CD33+ cells using LhEpoRSN. We have previously shown that erythroid progenitor cells are highly enriched, relative to other progenitors in populations of CD34+++ HLA-DR+CD33-bone and CD34++CD33-cord b10od."~ Therefore, we evaluated the influence on colony formation B I of pLhEpoRSN treatment of CD34++ subsets of CD33-and CD33+ cells (Fig 5) . Cells were grown in the absence and presence of 1.0 mg G418/mL, and in the presence of 1.0 U Epo/mL plus SLF, GM-CSF, and IL-3. Results shown are from two experiments in which 96 to 192 wells with a single cell/well for each treatment point were evaluated. The cloning efficiency for BFU-E and CFU-GEMM (mock controls without G418) was greater in the CD33-than CD33' cells and only a few CFU-GM clusters (small aggregates) from both populations of the mock controls survived to grow in G418. The cloning efficiencies of BFU-E and CFU-GEMM in both CD33-and CD33+ subsets of CD34++ cells were significantly increased and the cloning efficiency for HPP-CFC was significantly decreased in the LhEpoRSN versus
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use only. that LhEpoRSN-treated cells also had significantly fewer CFU-GM colonies than didthe mock-treated cells. This 18% decrease in CFU-GM was not as great as the 88% decrease in HPP-CFC, and the CFU-GM results in part reflect in part a decrease in the numbers of larger CFU-GM colonies that were not big enough to be classified as HPP-CFC. The percentages of G41SR BFU-E, CFU-GEMM, and CFU-GM were, respectively, 53%, 59%, and 68% for the CD33-subset and 90%, 69%, and 96% for the CD33' subset (Fig 5) .
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The percentage of G418R colonies positive by PCR and RT-PCR analysis for the CD33-and CD33' subsets is shown in Table 2 . Examples of the PCR amplified products for the CD33-cells are shown in Fig 6. Fifty-five to 71% of the G418R colonies were PCR' and 46% to 59% of these were positive for message expression by RT-PCR analysis.
In all the studies of PCR and RT-PCR analysis of individual colonies, all colonies were either positive for both the viral hEpoR and neo probes or negative for both probes.
Human EpoR gene transduction into populations of sorted progenitor cells. The single cell experiments described above were performed by placing a single cell into a well already containing the described growth factor combinations before adding the virus-containing supernatant with or without the later addition of G418. Because single cells cannot be washed without very large losses of cells, it was not possible to wash the single cells before or after the addition of virus. Thus, the transduced cells were left in the combination of growth factors they were in before the addition of virus. To determine if the addition of Epo after but not before treatment of cells with virus would change the results, CD34+", CD34+'CD33-, and CD34"CD33+ cells were pretreated for 2 days with SLF, GM-CSF, and IL-3; washed; treated with virus supernatant; washed, then plated at 200 cells/mL or after limiting dilution for CD34++' cells at 21 well in various growth factor combinations with and without Epo. As shown in Table 3 , the hEpoR gene transduced cells treated in this manner responded in the same way as described above in the single celVwell experiments. In the presence of Epo, the hEpoR transduced cells (verified by G418R and PCR analysis as >50% positive for the hEpoR gene for each progenitor cell type; data not shown) showed consistent significantly enhanced colony formation and cloning efficiency for BFU-E and CFU-GEMM and significantly decreased cloning efficiency for HPP-CFC. In the absence of Epo, no BW-E or CFU-GEMM colonies formed (data not shown). In two separate experiments in which cells were plated at 200 cells/mL, 20 of the largest consecutive BFU-E colonies in each experiment were removed from the SLF-, hEpoR-, and mock supernatant-treated cells and the number of cells was counted per colony. The number of cellskolony for the EpoR gene transduced cells was 45% to 53% greater than for the mock-virus-treated cells.
DISCUSSION
There are a number of clinical conditions in which it would be potentially beneficial to enhance the growth and numbers of specific hematopoietic progenitor cell types to amplify the production of their lineage-committed progeny. Because cytokine receptors are intimately involved in the production of end stage cells from stem and progenitor cells, it is possible that expression of certain cytokine receptors on the surface of cells that lack these receptors or increased expression of these receptors on the surface of cells that express them at low concentration may allow for increased output of specific progenitor cell types and their progeny. In this context, we addressed the possibility that transduction of a hEpoR gene into cord blood stedprogenitor cells by retroviral vectors might allow for enhanced detection of erythroid progenitors after stimulation of the transduced cells with Epo. However, to be sure that any increases in numbers of erythroid cells that might be seen were due solely to the effects of the gene transduced into a progenitor cell and were not influenced by an accessory cell population during the start of cell culture, we felt it necessary to perform the gene transduction and subsequent growth stimulation of the transduced cells at the single isolated cell level.
We had previously shown that phenotypically sorted cells from cord blood could be stimulated to form colonies at high cloning efficiencies when these cells were isolated as a single c e l I /~e l l~~ and that these single cells could be transduced with a marker gene at high efficiency.32 Based on the viral titer, the ratio of virus to target cells in the present experiment was 10" particleskeli for the single cell gene transduction protocol, whereas it was only 16 particleskell for the bulk cell gene transduction protocol. The studies were performed use only. Purified cells were incubated at less than 2 x lo5 cells/mL for 2 days in the presence of 200 U/mL rhGM-CSF, 200 U/mL rhlL-3, and 50 ng/mL rhSLF and exposed to either LhEpoRSN or mock control viral supernatant. Cells were washed twice and plated as either 200 cellslmL in the presence of 200 U/mL rhGM-CSF, 200 U/mL IL-3, 50 ng/mL rhSLE, and 1 U/mL rhEpo (A) or after limiting dilution at 2 cells/well in the presence of 200 U/mL rhGM-CSF, 200 UlmL rhlL-3, 50 n g h L SLF, and 1 U/mL rhEpo (B, #l) or 200 U/mL rhlL-3 and 1 U/mL rhEpo (B, #2). Note that, in (A), these are the results of two different experiments in which CD34"CD33-and CD34"CD33' cells were isolated from one sample that was different from the sample used for CD34+++ cells. In (B), the samples for # l and #2 were the same except for the addition of different growth factor combinations after the transduction procedure.
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For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From when Epo was added to the single cell cultures. This showed that the transduction did not confer on the cells the capacity to differentiate without Epo. The addition of Epo only enhanced colony formation of CFU-GEMM and BFU-E compared with the mock controls. It is unclear at this time whether this Epo-induced enhancement of cloning efficiency for the transduced CFU-GEMM and BFU-E was due to expression of EpoR in cells not previously expressing EpoR or to an enhanced expression of EpoR in cells already expressing EpoR. Receptor-ligand binding studies would be informative here, but the low cell numbers preclude obtaining information on EpoR number or affinity on the purified cells and such studies cannot be performed on the single transduced cell. Additionally, after numerous attempts we were not able to detect EpoR on transduced or nontransduced cells using EpoR antibodies and flow cytometric analysis. However, increased EpoR protein was noted in M07ER cells:' in which we used this same hEpoR gene-containing virus to transduce M07e cells with an EpoR. The M07ER, but not M07e, cells were responsive to stimulation by Epo.
In the hierarchy of stedprogenitor cells, HPP-CFC are usually considered more immature than, and possibly precursors of, CFU-GEMM, BFU-E, and CFU-GM. Thus, it is possible that the addition of hEpoR genes into HPP-CFC allowed at least some of these cells to differentiate to become CFU-GEMM or BFU-E on exposure to Epo. This would be consistent with the associated decrease in HPP-CFC numbers and increase in numbers of BFU-E and CFU-GEMM. The reduced numbers of HPP-CFC was not due to the toxic effect of viruses because the effects of the EpoR cDNA-containing retroviral vectors were compared with mock controls using the same retroviral vectors without the EpoR cDNA insert, and the mock controls had more HPP-CFC colonies than the experimental points. Moreover, the same number of colonies of all types (including those derived from HPP-CFC) were seen in mock-treated versus control medium-treated cells. These results are consistant with those of our previous studies in which viral vectors containing TK neo32 or Fanconi anemia complementation C44 genes have no toxic effects on HPP-CFC. Interestingly, there were significantly reduced numbers of HPP-CFC detected in the transduced population of cells, even in the absence of added Epo without the detection of CFU-GEMM or BFU-E. This, too, could have occurred because the expression of EpoR in HPP-CFC converted those cells to Epo dependence and the cells were then unable to survive in the absence of Epo. However, the results on expression of EpoR by RT-PCR, as noted above regarding Fig 3, may not be compatible with this view. If EpoR-transduced HPP-CFC became committed as a result of EpoR expression, we might have expected that the observed ratio of untransduced (HPP-CFC colonies not expressing EpoR) to transduced HPP-CFC colonies would have increased. No such increase was observed. Because we cannot be sure how much EpoR was actually expressed on the cell surface, our interpretation regarding whether expression of EpoR in HPP-CFC is sufficient to induce commitment to erythropoiesis needs to be considered cautiously. Another explanation for the drop in HPP-CFC after EpoR expression may be by a mechanism similar to that observed for macrophage (M)-CSF receptor expression?6 The addition of GM-CSF or IL-3 to murine FDC-PlMAC cells that express IL-3R, GM-CSFR, and M-CSFR suppresses expression of M-CSFR by a posttranscriptional mechanism in a dose-dependent manner. However, in our experiments, the presence of EpoR reduced numbers of HPP-CFC even in the absence of Epo. A possible model for this observation is that, by its presence, EpoR is able to compete for molecules critical for signalling by other early growth factor receptors, such as GM-CSFR, c-kit, and IL-3R. Consonant with this idea, communication between the GM-CSF receptor and EpoR has been investigated at the molecular level, and a distinct cytoplasmic region of EpoR is able to downmodulate signalling from the GM-CSFR.47 EpoR and IL-3 also share JAK2, a protein critical for signalling.48.4' Further investigation of growth factor receptor communication at the molecular level should begin to show mechanisms of lineage restriction and differentiation.
The mere transduction of the hEpoR gene into certain cells and its expression, even in the presence of Epo, was not by itself enough to change the differentiation profile of certain cells. CFU-GM were found to contain and express the transduced hEpoR gene, yet little or no change was noted in this cell population, and when small changes were noted, this was not found to be a consistent effect. This could mean that CFU-GM are already committed to the granulocytemacrophage pathway and that this differentiation profile could not be changed by the expression of the EpoR gene. It is also possible that the EpoR protein levels on the surface of CFU-GM were not high enough to allow them to bind Epo effectively or that the receptor molecules were in high enough quantity but intracellular molecules necessary to transmit the signal were not available. In this context, it is of interest that certain human and murine factor-dependent cell lines that grow in the presence but not absence of certain cytokines did not respond to Epo, but had the intracellular machinery to respond to Epo once these cells were transduced with an EpoR gene.2"23,36 At the present time, without the means to assess the numbers and affinity of EpoR on the transduced cells and the signalling molecules in these cells, we cannot differentiate between these possibilities. The fact that the cells transduced with the EpoR gene did not form CFU-GEMM or BFU-E in the absence of Epo suggests that the process of transduction of the hEpoR gene did not induce autonomous growth.
Future studies will need to assess whether such transduction procedures actually affect long-term marrow repopulating cells and if self-renewal is decreased at the expense of differentiation. 
